Low-dose hormone therapy in postmenopausal women in China

References

• Speroff L, Fritz MA. Postmenopausal hormone therapy. In Clinical Gynecologic Endocrinology and Infertility, 7th edn. Philadephia: Lippincott Williams & Wilkins, 2005:689–778
   Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–333
   PubMed Web of Science ®Google Scholar
• Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–427
   PubMed Web of Science ®Google Scholar
• Pines A, Sturdee DW, Birkhauser MH, et al IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007;10:181–194
   PubMed Web of Science ®Google Scholar
• Peeyananjarassri K, Baber R. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric 2005;8:13–23
   PubMed Web of Science ®Google Scholar
• Panay N, Ylikorkala O, Archer DF, et al Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric 2007;10:120–131
   PubMed Web of Science ®Google Scholar
• Lundstrom E, Bygdeson M, Svane G, et al Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density. Climacteric 2007;10:249–256
   PubMed Web of Science ®Google Scholar
• Speroff L, Fritz MA. Menopause and the perimenopausal transition. In Clinical Gynecologic Endocrinology and Infertility, 7th edn Philadephia: Lippincott Williams & Wilkins, 2005:621–688
   Google Scholar
• Obermeyer CM. Menopause across cultures: a review of the evidence. Menopause 2000;7:184–192
   PubMed Web of Science ®Google Scholar
• Hilditch JR, Chen S, Norton PG, et al Experience of menopausal symptoms by Chinese and Canadian women. Climacteric 1999;2:164–173
   PubMedGoogle Scholar
• Haines CJ, Xing SM, Park KH, et al Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 2005;52:264–276
   PubMed Web of Science ®Google Scholar
• Chen Y, Lin SQ, Wei Y, et al Impact of menopause on quality of life in community-based women in China. Menopause 2008;15:144–149
   PubMed Web of Science ®Google Scholar
• Tian FL, Yang DZ, Zhang XZ, et al [Survey of health status and healthcare service demand of perimenopausal women in Guangdong]. Di Yi Jun Yi Da Xue Xue Bao 2004. 24:928–932
   PubMedGoogle Scholar
• Lam PM, Leung TN, Haines C, et al Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40–60 years. Maturitas 2003;45:99–107
   PubMed Web of Science ®Google Scholar
• Zhang SW, Wang JH, Zhou H, et al [The investigation and analysis of the factors related with the menopausal age of women in Beijing area]. Beijing Med J 2002;24:177–180
   Google Scholar
• Deng XH, Zhang SW. [The epidemiological survey of perimenopausal women in Beijing]. Beijing Med J 2002;24:235–238
   Google Scholar
• Chen Y, Lin SQ, Wei Y, et al Menopause-specific quality of life satisfaction in community-dwelling menopausal women in China. Gynecol Endocrinol 2007;23:166–172
   PubMed Web of Science ®Google Scholar
• Yang D, Haines CJ, Pan P, et al Menopausal symptoms in mid-life women in southern China. Climacteric 2008;11:329–336
   PubMed Web of Science ®Google Scholar
• MacLennan AH, Taylor AW, Wilson DH. Hormone therapy use after the Women's Health Initiative. Climacteric 2004;7:138–142
   PubMed Web of Science ®Google Scholar
• Xia JH, Tian FL, Zhao QG, et al [Investigation on women's menopause treatment and attitude toward hormone replacement therapy]. China Public Health 2005;21:83–84
   Google Scholar
• Ye BL, Lin QY. [Survey of status of postmenopausal women in Wenzhou District]. Zhonghua Fu Chan Ke Za Zhi 1997;32:557–558
   Google Scholar
• Zhang SC, Wei XL, Geng LP, et al [Progress of healthcare service in perimenopausal women]. Nursing J Chinese People's Liberation Army 2004;21:44–45
   Google Scholar
• [National Symposium on Issues of Perimenopausal and Postmenopausal Women – Summary]. Zhonghua Fu Chan Ke Za Zhi 1997;32:520–523
   PubMedGoogle Scholar
• Zhou YZ, Lin SQ, Jiang YX, et al [Effects of continuous combined estrogen and progesterone for a year on breast in postmenopausal women]. Zhonghua Fu Cha Ke Za Zhi 2003. 38:34–35
   Google Scholar
• Ge Q, Tian Q, Tseng H, et al Development of low-dose reproductive hormone therapies in China. Gynecol Endocrinol 2006;22:636–645
   PubMed Web of Science ®Google Scholar
• OCPS research group in Shanghai. [Clinical and laboratory research on reduced doses of oral contraceptives]. Family Plann Drugs (Chin) 1978;1:S77–98
   Google Scholar
• Du Z, Sun M, Wang B, et al [The effects of sex hormone on blood vessels]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1999;21:282–287
   PubMedGoogle Scholar
• Nie M, Sun ML, Ge QS. [Effects of long-term and low-dose hormone replacement therapy on bone mineral density in postmenopausal women]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006;28:421–424
   PubMedGoogle Scholar
• Hu L, Yue Y, Zuo PP, et al Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner. Chin Med Sci J 2006;21:214–218
   PubMedGoogle Scholar
• Luan Q, Luan MY, Li GZ. [Prospective study of low dose hormonal replacement therapy on the treatment of climacteric symptoms in postmenopausal women]. J Weifang Med Coll 1998;20:81–82
   Google Scholar
• Xing S, Wu Y, Liu J, et al A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin. Chin Med J (Engl) 2003;116:584–587
   PubMed Web of Science ®Google Scholar
• Tan D, Haines CJ, Limpaphayom KK, et al Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia menopause (PAM) study. Maturitas 2005;52:35–51
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Dong ZN, Liu H, et al [Effects of continuous combined Dermstril and medroxyprogesterone acetate replacement therapy on climacteric symptoms and lumbar vertebral bone loss]. J Reprod Med 2002;11:274–278
   Google Scholar
• Bai WP, Chen SL, Zheng SY, et al [The treatment effect of transdermal estrogen patches on menopausal syndrome and its effect on serum lipoprotein metabolism]. Maternal Child Health Care China 2005;20:499–501
   Google Scholar
• Kenemans P, Speroff L. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas 2005;51:21–28
   PubMed Web of Science ®Google Scholar
• Cheng J, Ye BL, Li CY. [Effects of low dose hormone replacement therapy on cardiovascular system in postmenopausal women]. J Chinese Ageing 2005;25:1308–1310
   Google Scholar
• Song YX, Guan Y, Liu Y. [Therapeutic study of low dose hormone treatment in postmenopausal women]. J Med Forum 2008;29:71–72
   Google Scholar
• Wu FL, Wu YY, Shi HY. [Effects of different types of low dose sex hormone on quality of life in postmenopausal women]. Chin J Med 2006; 41:36–37
   Google Scholar
• Haines CJ, Yim SF, Chung TK, et al A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women. Maturitas 2003;44:207–214
   PubMed Web of Science ®Google Scholar
• Lu J, Lin S, Zhang L, et al [Prevention of bone loss by estradiol valerate combined with medroxyprogesterone acetate among postmenopausal women with osteopenia]. Zhonghua Yi Xue Za Zhi 2002;82:1593–1598
   PubMedGoogle Scholar
• Weng SQ. [Low dose of estrogen on treatment of postmenopausal osteoporosis]. Reprod Contracept 2007;27:794–797
   Google Scholar
• Sun A, Lin S, Wei Y. [Observation of preventing of bone loss during early postmenopause by percutaneous estradiol in Chinese postmenopausal women]. Zhonghua Fu Chan Ke Za Zhi 2001;36:348–351
   PubMedGoogle Scholar
• Li LZ, Gao ZQ, Zhang PS, et al [Effects of low dose hormonal replacement therapy on bone metabolism in postmenopausal women]. J Clin Orthopaedics 1998;1:30–1
   Google Scholar
• Wu YY, Liu JL, Xing SM, et al [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis]. Zhonghua Fu Chan Ke Za Zhi 2002;37:762–765
   Google Scholar
• Shang M, Yang X, Luan YQ, et al [Effects of small dose estrogen and progesterone on prevention and treatment of perimenopausal osteoporosis]. Chin J Osteoporos 2005;11:424–426
   Google Scholar
• Li WQ, Zhou ZL, Li X, et al [Study on the therapeutic effect of small dose of estradiol and progestrone on post-menopauseal osteoporosis]. J Radioimmunol 2004;17:1–3
   Google Scholar
• Gambacciani M, Cappagli B, Ciaponi M, et al Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women. Maturitas 2008;59:2–6
   PubMed Web of Science ®Google Scholar
• Ausmanas MK, Holinka CF, Ling YS, et al Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study. Climacteric 2007;10:306–313
   PubMed Web of Science ®Google Scholar
• He FF, Sun AJ, Qin MW, et al [The effect of low dose Livial in prevention and management of postmenopausal women]. J Reprod Med 2000;9:71–76
   Google Scholar
• Luan Q, Li LZ, Luan MY, et al [Effects of low dose of hormone replacement therapy on lipids in postmenopausal women]. Zhonghua Fu Chan Ke Za Zhi 2000;35:181–182
   Google Scholar
• Luan MY, Luan Q, Li LZ. [Effects of low dose hormonal replacement therapy on glucose metabolism in postmenopausal women]. J WeiFang Med Coll 1998;20:87–88
   Google Scholar
• Shi YF, Yang WW. [The effect of lower doses hormone replacement therapy on homocysteine serum level in postmenopausal women]. J Bethune Military Med Coll 2005;3:77–79
   Google Scholar
• Sadoon S, Salman G, Smith G, et al Ultrasonographic endometrial thickness for diagnosing endometrial pathology in postmenopausal bleeding. J Obstet Gynaecol 2007;27:406–408
   PubMedGoogle Scholar
• Chen R, Lin S, Yang X, et al [A randomized, mutlti-center, double blind and parallel controlled clinical trial for Kuntai capsules in the treatment of climacteric syndromes]. Chin J New Drugs 2005;14:1472–1476
   Google Scholar
• Gong LL, Zhang SF, Ji L, et al [Effect of low-dose hormone therapy on breast at the early stage of menopause]. J Pract Obstet Gynecol 2009;25:104–107
   Google Scholar
• Wang SH, Lin SQ, Gui QF, et al [Profiles of irregular bleeding induced by low-dose hormone therapy and Chinese formulated herbs products]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006;28:256–261
   PubMedGoogle Scholar
• Wang ZQ, Liu J. [Recent progress of nylestriol in preventing postmenopausal osteoporosis and lipoprotein lipids disorders]. Chin J New Drugs 1996;5:335–338
   Google Scholar
• Liu JL. [Effect of nylestriol on postmenopausal uterine endometrium]. Zhonghua Fu Chan Ke Za Zhi 1993;28:76–78, 122
   PubMedGoogle Scholar
• Cheng GJ, Liu JL, Zhang Q, et al Nylestriol replacement therapy in postmenopausal women. A three-year prospective study. Chin Med J (Engl) 1993;106:911–916
   PubMed Web of Science ®Google Scholar
• Zhang JF, Yang JL, Zhou MZ, et al [Lipids regulating effects of small dose nylestriol on lipoprotein(a) and lipids in postmenopausal woman]. Clin Cardiol (China) 1999;15:122–124
   Google Scholar
• Liao EY, Luo XH, Deng XG, et al The effect of low dose nylestriol-levonorgestrel replacement therapy on bone mineral density in women with postmenopausal osteoporosis. Endocr Res 2003;29:217–226
   PubMed Web of Science ®Google Scholar
• Cheng GJ. [Prospective study on nylestriol replacement therapy in postmenopausal women]. Zhonghua Fu Chan Ke Za Zhi 1993;28:534–538
   PubMedGoogle Scholar